Tango Therapeutics Inc

General ticker "TNGX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $367.6M

Tango Therapeutics Inc does not follow the US Stock Market performance with the rate: -26.2%.

Estimated limits based on current volatility of 5.1%: low 2.85$, high 3.15$

Factors to consider:

  • Current price 54.0% below estimated low
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [7.02$, 14.03$]
  • 2024-12-30 to 2025-12-30 estimated range: [6.25$, 12.79$]

Financial Metrics affecting the TNGX estimates:

  • Negative: Non-GAAP EPS, $ of -1.10 <= 0.10
  • Negative: Operating profit margin, % of -75.76 <= 1.03
  • Negative: Operating cash flow per share per price, % of -12.11 <= 2.35
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85

Similar symbols

Short-term TNGX quotes

Long-term TNGX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $37.04MM $24.86MM $36.53MM
Operating Expenses $95.23MM $135.93MM $150.70MM
Operating Income $-58.19MM $-111.07MM $-114.17MM
Non-Operating Income $0.25MM $2.95MM $12.56MM
R&D Expense $77.64MM $105.91MM $115.20MM
Income(Loss) $-57.94MM $-108.12MM $-101.61MM
Taxes $0.29MM $0.05MM $0.13MM
Profit(Loss) $-58.23MM $-108.18MM $-101.74MM
Stockholders Equity $344.75MM $249.48MM $253.11MM
Inventory $0.57MM $0.57MM $0.00MM
Assets $500.15MM $436.47MM $402.57MM
Operating Cash Flow $-59.53MM $-109.08MM $-117.98MM
Capital expenditure $1.84MM $7.69MM $1.53MM
Investing Cash Flow $-183.43MM $26.40MM $41.43MM
Financing Cash Flow $357.32MM $1.61MM $82.41MM
Earnings Per Share* $-0.94 $-1.23 $-1.08

* EPS are Split Adjusted, recent splits may be reflected with a delay.